This HTML5 document contains 52 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n12http://en.wikipedia.org/wiki/Psychotropic_Substances_Act_(Thailand)
n14http://caligraph.org/ontology/Schedule_IV_drug_(US)
n6http://en.wikipedia.org/wiki/Category:
n11http://en.wikipedia.org/wiki/Decree-Law_15/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n10http://en.wikipedia.org/wiki/List_of_Schedule_IV_drugs_(US)
n15http://en.wikipedia.org/wiki/List_of_MeSH_codes_(D03)
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
clgohttp://caligraph.org/ontology/
n7http://en.wikipedia.org/wiki/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://en.wikipedia.org/wiki/List_of_drugs:_Pb%E2%80%93
n17http://caligraph.org/ontology/MeSH_code_(D03)
dbrhttp://dbpedia.org/resource/
clgrhttp://caligraph.org/resource/
Subject Item
clgr:Pemoline
rdf:type
clgo:Oxazolidinone clgo:Banned_substance_in_Major_League_Baseball clgo:Stimulant clgo:AbbVie_brand n14: clgo:Aminorex_analogue clgo:Norepinephrine-dopamine_releasing_agent clgo:Drug_banned_by_the_World_Anti-Doping_Agency clgo:Investigational_attention_deficit_hyperactivity_disorder_drug clgo:Compounds_with_carbon_number_9 n17: clgo:Substance_discovered_in_the_1910s owl:NamedIndividual clgo:Withdrawn_drug clgo:Hepatotoxin
rdfs:label
Pemoline
owl:sameAs
dbr:Pemoline
prov:wasDerivedFrom
n6:Substances_discovered_in_the_1910s n7:List_of_compounds_with_carbon_number_9 n6:Stimulants n7:Tourettism n7:List_of_drugs_banned_by_the_World_Anti-Doping_Agency n7:List_of_withdrawn_drugs n7:Drugs_controlled_by_the_UK_Misuse_of_Drugs_Act n10: n11:93 n12: n6:Oxazolidinones n13:Pe n7:Opium_Law n7:List_of_banned_substances_in_Major_League_Baseball n7:Convention_on_Psychotropic_Substances n6:Norepinephrine-dopamine_releasing_agents n6:AbbVie_brands n7:Misuse_of_Drugs_Act_1977 n6:Withdrawn_drugs n15: n7:List_of_investigational_attention_deficit_hyperactivity_disorder_drugs n7:Sympathomimetic_drug n7:Drug_policy_of_India n6:Hepatotoxins n7:List_of_aminorex_analogues
skos:prefLabel
Pemoline
skos:altLabel
pemoline
clgo:alternativeName
Cylert, others
clgo:casNumber
2152-34-3
clgo:chEBI
7953
clgo:chEMBL
1177
clgo:drugbank
DB01230
clgo:fdaUniiCode
7GAQ2332NK
clgo:kegg
D00744
clgo:pubchem
4723